共 50 条
- [9] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519
- [10] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519